Key Record Dates
ClinicalTrials.gov Identifier: | NCT03069378 |
---|---|
Brief Title: | A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma |
First Submitted : | February 27, 2017 |
First Submitted that Met QC Criteria : | February 27, 2017 |
First Posted : | March 3, 2017 |
Last Update Submitted that Met QC Criteria : | November 20, 2023 |
Last Update Posted : | November 21, 2023 |